Page 6,706«..1020..6,7056,7066,7076,708..6,7206,730..»

Pt 8 Shawn

Posted: Published on July 4th, 2012

03-07-2012 07:34 Pt 8 of Inspirational speakers Shawn and Kate Rickel speaking at the Brain Injury Association in Kansas City in April 2011. See exactly how the present their amazing story of surviving traumatic brain injury and the miraculous recovery back to a normal life. For information about how you can have Shawn and Kate Rickel speak at your organization, please contact: Shawn or Kate Rickel - - 303.278.3351 Read the rest here: Pt 8 Shawn … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Pt 8 Shawn

Children with genetic disorder write to Chief Minister for help

Posted: Published on July 4th, 2012

V. Rajendran and Sujatha have a six-year-old boy, Raghu, who has been diagnosed with LSD (Lysosomal Storage Disorder) and requires medicines costing Rs. 98,000 per dose. He needs two doses every month. Raghus older sister does not share his genetic problem or understand the seriousness of the situation as she plays with her brother. We realised his growth was abnormal when he was 18 months old, Mr. Rajendran said. Diagnosis of the disease was the easier part. If the dose is not administered on time, he suffers from swelling of liver and spleen, he said. Like Raghu, there are 150 children in the State and while some of them need expensive medicines to manage their condition, others need correctional surgeries. LSD is a group of 45 different genetic diseases, caused by lack of secretion of certain enzymes in the body. K. Divya (16), a class XI student, looks like a two-year-old. There are no medicines to treat her, however. Her appearance on a television show helped her get admission in school, said her father J. Karunakaran, who also spearheaded a movement called the LSD Support Society to bring together such children and their parents. Divya scored 92 per cent in … Continue reading →

Comments Off on Children with genetic disorder write to Chief Minister for help

Stem Cell Therapy Shown to be Effective in Treating Liver Cirrhosis

Posted: Published on July 4th, 2012

SHENZHEN, China, July 3, 2012 /PRNewswire-Asia/-- A study conducted by Beike Biotechnology Company (http://www.beikebiotech.com) in conjunction with physicians and researchers at two Chinese hospitals, documents the effectiveness of cord blood-derived stem cells in treating primary biliary cirrhosis (PBC). The study, which was published in the April 2012 issue of the Stem Cell Discovery, was the first of its kind. Researchers noted that additional clinical trials would be required before stem cells can become an accepted therapy for liver cirrhosis. Prof. Jin-hui Yang, Director of the Department of Hepatology in the 2nd Affiliated Hospital of Kunming Medical College stated, "Given the severity of liver cirrhosis and its related conditions, and the limited number of options available to treat those who suffer from it, this finding represents an important, potentially significant breakthrough." PBC is a chronic, progressive liver disease that leads eventually to fibrosis and cirrhosis of the liver. It affects 1 in 1,000 women over the age of 40.Approximately one-third of those who suffer from PBC and its related conditions do not respond well to Ursodeoxycholic acid (UDCA) treatment, which is the only currently FDA-approved standard medical treatment for the condition. Many of those patients ultimately require liver transplantation. Beike Chairman, … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Stem Cell Therapy Shown to be Effective in Treating Liver Cirrhosis

Ireland could be stem cell research hub

Posted: Published on July 4th, 2012

Tuesday, July 03 16:25:12 Ireland has the capacity to be an international centre for commercialisation in the field of regenerative medicine, delegates at an international stem cell conference in NUI Galway heard today. Reflecting this potential, new Irish company Orbsen Therapeutics is developing proprietary technologies designed to isolate stem cells. The NUI Galway spin-out is targeting the rapidly maturing and expanding regenerative medicine market, which is expected to grow to $118 billion next year. Frank Barry is Professor of Cellular Therapy at NUI Galway, Director of Orbsen Therapeutics, and organiser of the Mesenchymal Stem Cell Conference, which opened yesterday. Mesenchymal stem cells (MSCs) are a type of adult stem cell, and this event brings together the world's leading scientists in the field to discuss their latest ideas and findings. This is the first major stem cell conference to take place in Ireland, and is looking at all aspects of adult stem cells, from basic biology to manufacturing to clinical trials and therapeutics. Stem cells hold great promise as an alternative to drugs and surgical procedures for treating a wide range of medical conditions including heart disease, arterial disease of the limbs, diabetes complications, arthritis and other inflammatory conditions. The treatment … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Ireland could be stem cell research hub

Angels 3, Indians 0: Tribe lays egg on scoreboard

Posted: Published on July 3rd, 2012

CLEVELAND: It was a game in which Indians batsmen couldnt be blamed for their impotency. They were, in fact, expected to struggle mightily Monday night against the Los Angeles Angels, who opened a three-game set at Progressive Field with a 3-0 win. Jered Weaver makes a habit of shutting down offenses much more explosive than the Tribes. And he had little trouble doing what he usually does, delivering seven scoreless innings, allowing five hits and three walks. Though Weaver (9-1, 2.13 ERA) is a load for any rival attack to handle, he has been especially lethal at Progressive Field, where he is 5-0 in eight starts. In fact, Weaver has the second lowest ERA of any pitcher who has made at least five starts on Tribe turf, lowering that figure to 1.52 Monday night. Unfortunately, we couldnt do much offensively, manager Manny Acta said. We didnt have a very good approach to Weaver the first five or six innings. Im not taking anything away from him, because he does this to teams every five days. But I felt we were swinging at his pitches, and we were swinging too early in the count. I know he was throwing strikes, but … Continue reading →

Posted in Impotency | Comments Off on Angels 3, Indians 0: Tribe lays egg on scoreboard

Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy …

Posted: Published on July 3rd, 2012

TAMPA, Fla., July 3, 2012 /PRNewswire/ --On behalf of Saneron CCEL Therapeutics, Inc., President and COO, Nicole Kuzmin-Nichols, MBA, expressed strong support today for the Cryo-Cell International, Inc. (CCEL) current executive management in response to a proxy bid by a former Board member. Cryo-Cell is a major shareholder in Saneron, a Tampa based biotechnology research and development company that was spun out from the University of South Florida to develop cellular therapies for deadly diseases that lack adequate treatment options. "Saneron has enjoyed a good working relationship with David and Mark Portnoy since they assumed leadership at Cryo-Cell in August 2011, and our board is convinced that their guidance is adding shareholder value," commented Kuzmin-Nichols. "They have shown themselves to be committed partners with Saneron as we continue breaking new ground in cord and menstrual blood stem cell research. Our Small Business Technology Transfer Program (STTR) Phase II efforts are producing real progress towards effective treatments for Alzheimer's disease and stroke and we look forward to continuing our research in concert with Cryo-Cell." "Our research team is very impressed with Dr. Linda Kelley, Cryo-Cell's new chief scientific officer, who joined the company from Harvard's Dana-Farber Cancer Institute. She will be … Continue reading →

Posted in Cell Medicine | Comments Off on Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy …

Ireland could be stem cell research hub

Posted: Published on July 3rd, 2012

Tuesday, July 03 16:25:12 Ireland has the capacity to be an international centre for commercialisation in the field of regenerative medicine, delegates at an international stem cell conference in NUI Galway heard today. Reflecting this potential, new Irish company Orbsen Therapeutics is developing proprietary technologies designed to isolate stem cells. The NUI Galway spin-out is targeting the rapidly maturing and expanding regenerative medicine market, which is expected to grow to $118 billion next year. Frank Barry is Professor of Cellular Therapy at NUI Galway, Director of Orbsen Therapeutics, and organiser of the Mesenchymal Stem Cell Conference, which opened yesterday. Mesenchymal stem cells (MSCs) are a type of adult stem cell, and this event brings together the world's leading scientists in the field to discuss their latest ideas and findings. This is the first major stem cell conference to take place in Ireland, and is looking at all aspects of adult stem cells, from basic biology to manufacturing to clinical trials and therapeutics. Stem cells hold great promise as an alternative to drugs and surgical procedures for treating a wide range of medical conditions including heart disease, arterial disease of the limbs, diabetes complications, arthritis and other inflammatory conditions. The treatment … Continue reading →

Posted in Cell Medicine | Comments Off on Ireland could be stem cell research hub

Stem Cell Therapy Shown to be Effective in Treating Liver Cirrhosis

Posted: Published on July 3rd, 2012

SHENZHEN, China, July 3, 2012 /PRNewswire-Asia/-- A study conducted by Beike Biotechnology Company (http://www.beikebiotech.com) in conjunction with physicians and researchers at two Chinese hospitals, documents the effectiveness of cord blood-derived stem cells in treating primary biliary cirrhosis (PBC). The study, which was published in the April 2012 issue of the Stem Cell Discovery, was the first of its kind. Researchers noted that additional clinical trials would be required before stem cells can become an accepted therapy for liver cirrhosis. Prof. Jin-hui Yang, Director of the Department of Hepatology in the 2nd Affiliated Hospital of Kunming Medical College stated, "Given the severity of liver cirrhosis and its related conditions, and the limited number of options available to treat those who suffer from it, this finding represents an important, potentially significant breakthrough." PBC is a chronic, progressive liver disease that leads eventually to fibrosis and cirrhosis of the liver. It affects 1 in 1,000 women over the age of 40.Approximately one-third of those who suffer from PBC and its related conditions do not respond well to Ursodeoxycholic acid (UDCA) treatment, which is the only currently FDA-approved standard medical treatment for the condition. Many of those patients ultimately require liver transplantation. Beike Chairman, … Continue reading →

Posted in Cell Therapy | Comments Off on Stem Cell Therapy Shown to be Effective in Treating Liver Cirrhosis

Fined $3b: drug giant hid harmful side effects

Posted: Published on July 3rd, 2012

"Direct medical harm would have been done" ... Professor Jon Jureidini. DRUG company GlaxoSmithKline will pay US authorities $3 billion for fraudulently promoting drugs for diabetes and mental illness, in the largest healthcare fraud settlement in US history. The drug company admitted it had promoted unproven use of an antidepressant, sold as Aropax here and Paxil overseas, for children, and did not disclose research linking it to suicidal thoughts. Australian researchers played a key role in exposing the illegal marketing of the drug, revealing significant flaws in a research paper used to promote it. Advertisement: Story continues below Aropex ... fraudulently promoted for the treatment of diabetes and mental illness. The company has also admitted to other such "off-label" marketing, as well as attempting to cover up the increased risk of heart problems linked to its diabetes drug, Avandia. But the record fine may have little impact on the UK drug behemoth, which had a total turnover last year of $42 billion, according to its annual report. The head of the department of psychological medicine at the Adelaide Women's and Children's Hospital, Jon Jureidini, said it was distressing that even such record fines were a ''necessary cost of doing business''. … Continue reading →

Posted in Drug Side Effects | Comments Off on Fined $3b: drug giant hid harmful side effects

Codes back away from Stilnox ban

Posted: Published on July 3rd, 2012

First introduced to the Stilnox in 2003 ... Grant Hackett. Photo: Reuters AS THE Australian Olympic Committee came to terms with revelations the use of sleeping tablet Stilnox was widespread at the Athens and Beijing Games, Australia's four largest sporting codes have said they won't be following John Coates's lead by banning the drug. The AOC moved yesterday to ban all its athletes from using the prescribed sleeping drug after a phone call from disgraced former swimmer Grant Hackett to Coates in which Hackett detailed how rampant the drug's use was in swimming. ''Grant Hackett telephoned me to tell me that he was first introduced to the drug in 2003 at the world swimming championships in Barcelona,'' Coates said yesterday. Advertisement: Story continues below ''He asked the team doctor for the temazepam, which he presumably knew something about, and instead he was prescribed Stilnox. And he told me that that was then being prescribed as normal practice by our swimming and Olympic team doctors in Athens.'' As a result, Coates accepted the blame for not being aware of the issue sooner and implementing change. And he has instructed AOC officials to amend the official medical manual to include the ban … Continue reading →

Posted in Drug Dependency | Comments Off on Codes back away from Stilnox ban

Page 6,706«..1020..6,7056,7066,7076,708..6,7206,730..»